Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers (Q64801916)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers |
clinical trial |
Statements
The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers (English)
0 references
17 February 2016
0 references
December 2020
0 references
35
0 references
18 year
0 references
30 year
0 references